Skip to main content
Equibles
MCRB logo

MCRB · Seres Therapeutics, Inc. · Share Buybacks

Track MCRB — free

Use MCRB with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MCRB.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.35 -0.13 (-3.74%) At close · Sep 30
Rebalance outlook locked
Going-concern doubt — flagged Aug 5, 2026

Substantial doubt about the company's ability to continue as a going concern.

“these conditions raise substantial doubt about the Company's ability to continue as a going concern. ... As a result, management has concluded that substantial doubt exists about the Company's ability to continue as a going concern for 12 months from the date these condensed consolidated financial statements are issued.”
View the 10-Q filed Aug 5, 2026
Market Cap
$34.99M
Shares
9.94M
Volume · Sep 30 54.61K Avg daily vol (3M) 73.92K

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Repurchase History

Fiscal Year Ended Cash Spent
2017-12-31 $33,000
Key facts CIK 1609809 CUSIP 81750R201 13F (30d) 2 filings 2 filers Visit website Investor relations